Center for U.S. Policy
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • About
  • Issues
  • Initiatives
  • Events
  • Media
AOAT Opposes Modernizing Opioid Treatment Access Act

AOAT Opposes Modernizing Opioid Treatment Access Act

News June 7, 2023
Availability of Buprenorphine for OUD Uncertain

Availability of Buprenorphine for OUD Uncertain

News May 31, 2023
FDA Approves Weekly Injectable Buprenorphine

FDA Approves Weekly Injectable Buprenorphine

News May 24, 2023
FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning

FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning

News May 23, 2023
Good Intentions Alone Won’t Reduce Drug Poisonings

Good Intentions Alone Won’t Reduce Drug Poisonings

News May 16, 2023
Health Policy Advocates Petition FDA to Recall Software

Health Policy Advocates Petition FDA to Recall Software

News May 12, 2023
DEA Stonewalls FOIA Request

DEA Stonewalls FOIA Request

CUSP Research, News April 7, 2023
Barnes to Speak at 2023 Rx Summit

Barnes to Speak at 2023 Rx Summit

News April 6, 2023
Model Act Promotes SUD Treatment in EDs

Model Act Promotes SUD Treatment in EDs

News March 22, 2023
DEA Proposes Rules for Permanent Telemedicine Flexibilities

DEA Proposes Rules for Permanent Telemedicine Flexibilities

News March 1, 2023
Millennium Health Report on Polysubstance Use in 2022

Millennium Health Report on Polysubstance Use in 2022

News February 28, 2023
DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances

DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances

News February 28, 2023
Loading...
« Previous
Print page

© 2026 Center for U.S. Policy. All Rights Reserved.